NASDAQ · EYEHealthcareOphthalmic Goods

National Vision Holdings financials

$16.38+1.61%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Jan 3
FY24
Dec 28
FY23
Dec 30
FY22
Dec 31
FY21
Jan 1
FY20
Jan 2
FY19
Dec 28
FY18
Dec 29
FY17
Dec 30
Revenue$1.99B$1.82B$1.76B$1.64B$2.08B$1.71B$1.72B$1.54B$1.38B
Gross profit$1.17B$1.06B$1.02B$977.0M$1.17B$925.1M$917.8M$823.3M$738.3M
Gross margin58.8%58.1%58.2%59.4%56.5%54.0%53.2%53.6%53.7%
Operating income$58.6M-$10.5M$24.4M$52.8M$174.9M$87.0M$73.6M$42.4M$64.3M
Net income$29.6M-$28.5M-$65.9M$42.1M$128.2M$36.3M$32.8M$23.7M$43.1M
Net margin1.5%−1.6%−3.8%2.6%6.2%2.1%1.9%1.5%3.1%
Diluted EPS$0.37$-0.36$-0.84$0.52$1.43$0.44$0.40$0.30$0.70
EBITDA$160.5M$128.5M$128.5M$164.2M$281.2M$200.6M$169.7M$134.3M$137.4M
Operating cash flow$146.3M$133.6M$173.0M$119.2M$258.9M$235.0M$165.1M$106.6M$90.3M
Free cash flow$73.5M$38.1M$58.3M$5.7M$163.4M$158.2M$63.8M$2.1M-$3.0M
Diluted shares80.6M78.6M78.6M80.3M96.1M82.8M81.7M79.0M62.0M

Balance sheet

Period endJan 3Dec 28Dec 30Dec 31Jan 1Jan 2
Cash & equivalents$38.7M$73.9M$149.9M$229.4M$305.8M$373.9M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$245.9M$350.0M$461.3M$567.5M$570.1M$655.4M
Total assets$1.98B$2.01B$2.17B$2.29B$2.29B$2.33B
Total liabilities$1.11B$1.19B$1.34B$1.39B$1.37B$1.43B
Shareholders' equity$869.5M$816.3M$829.4M$901.1M$926.0M$906.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology